These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 21683129)
1. Development and characterization of immuno-nanocarriers targeting the cancer stem cell marker AC133. Bourseau-Guilmain E; Béjaud J; Griveau A; Lautram N; Hindré F; Weyland M; Benoit JP; Garcion E Int J Pharm; 2012 Feb; 423(1):93-101. PubMed ID: 21683129 [TBL] [Abstract][Full Text] [Related]
2. Post-insertion into Lipid NanoCapsules (LNCs): From experimental aspects to mechanisms. Perrier T; Saulnier P; Fouchet F; Lautram N; Benoît JP Int J Pharm; 2010 Aug; 396(1-2):204-9. PubMed ID: 20600733 [TBL] [Abstract][Full Text] [Related]
3. Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab' fragments. Béduneau A; Saulnier P; Hindré F; Clavreul A; Leroux JC; Benoit JP Biomaterials; 2007 Nov; 28(33):4978-90. PubMed ID: 17716725 [TBL] [Abstract][Full Text] [Related]
4. In vivo imaging of DNA lipid nanocapsules after systemic administration in a melanoma mouse model. David S; Carmoy N; Resnier P; Denis C; Misery L; Pitard B; Benoit JP; Passirani C; Montier T Int J Pharm; 2012 Feb; 423(1):108-15. PubMed ID: 21726617 [TBL] [Abstract][Full Text] [Related]
5. Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma. Huynh NT; Passirani C; Allard-Vannier E; Lemaire L; Roux J; Garcion E; Vessieres A; Benoit JP Int J Pharm; 2012 Feb; 423(1):55-62. PubMed ID: 21536115 [TBL] [Abstract][Full Text] [Related]
6. Lipid nanocapsule functionalization by lipopeptides derived from human papillomavirus type-16 capsid for nucleic acid delivery into cancer cells. Weyland M; Griveau A; Bejaud J; Benoit JP; Coursaget P; Garcion E Int J Pharm; 2013 Oct; 454(2):756-64. PubMed ID: 23769994 [TBL] [Abstract][Full Text] [Related]
7. The importance of the stem cell marker prominin-1/CD133 in the uptake of transferrin and in iron metabolism in human colon cancer Caco-2 cells. Bourseau-Guilmain E; Griveau A; Benoit JP; Garcion E PLoS One; 2011; 6(9):e25515. PubMed ID: 21966538 [TBL] [Abstract][Full Text] [Related]
8. CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells. Barrantes-Freer A; Renovanz M; Eich M; Braukmann A; Sprang B; Spirin P; Pardo LA; Giese A; Kim EL PLoS One; 2015; 10(6):e0130519. PubMed ID: 26086074 [TBL] [Abstract][Full Text] [Related]
9. Ferrociphenol lipid nanocapsule delivery by mesenchymal stromal cells in brain tumor therapy. Roger M; Clavreul A; Huynh NT; Passirani C; Schiller P; Vessières A; Montero-Menei C; Menei P Int J Pharm; 2012 Feb; 423(1):63-8. PubMed ID: 21554935 [TBL] [Abstract][Full Text] [Related]
10. Silencing of miR-21 by locked nucleic acid-lipid nanocapsule complexes sensitize human glioblastoma cells to radiation-induced cell death. Griveau A; Bejaud J; Anthiya S; Avril S; Autret D; Garcion E Int J Pharm; 2013 Oct; 454(2):765-74. PubMed ID: 23732394 [TBL] [Abstract][Full Text] [Related]
11. The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability. Paillard A; Hindré F; Vignes-Colombeix C; Benoit JP; Garcion E Biomaterials; 2010 Oct; 31(29):7542-54. PubMed ID: 20630585 [TBL] [Abstract][Full Text] [Related]
12. The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. Corbeil D; Röper K; Hellwig A; Tavian M; Miraglia S; Watt SM; Simmons PJ; Peault B; Buck DW; Huttner WB J Biol Chem; 2000 Feb; 275(8):5512-20. PubMed ID: 10681530 [TBL] [Abstract][Full Text] [Related]
13. Targeting cancer stem cells with an 131I-labeled anti-AC133 monoclonal antibody in human colorectal cancer xenografts. Lang J; Lan X; Liu Y; Jin X; Wu T; Sun X; Wen Q; An R Nucl Med Biol; 2015 May; 42(5):505-512. PubMed ID: 25669587 [TBL] [Abstract][Full Text] [Related]
14. Surface active properties of lipid nanocapsules. Mouzouvi CRA; Umerska A; Bigot AK; Saulnier P PLoS One; 2017; 12(8):e0179211. PubMed ID: 28796777 [TBL] [Abstract][Full Text] [Related]
15. Formulation and nebulization of fluticasone propionate-loaded lipid nanocarriers. Umerska A; Mouzouvi CR; Bigot A; Saulnier P Int J Pharm; 2015 Sep; 493(1-2):224-32. PubMed ID: 26183331 [TBL] [Abstract][Full Text] [Related]
16. Efficient in vitro gene therapy with PEG siRNA lipid nanocapsules for passive targeting strategy in melanoma. Resnier P; LeQuinio P; Lautram N; André E; Gaillard C; Bastiat G; Benoit JP; Passirani C Biotechnol J; 2014 Nov; 9(11):1389-401. PubMed ID: 25262914 [TBL] [Abstract][Full Text] [Related]
17. A Copper-Mediated Disulfiram-Loaded pH-Triggered PEG-Shedding TAT Peptide-Modified Lipid Nanocapsules for Use in Tumor Therapy. Zhang L; Tian B; Li Y; Lei T; Meng J; Yang L; Zhang Y; Chen F; Zhang H; Xu H; Zhang Y; Tang X ACS Appl Mater Interfaces; 2015 Nov; 7(45):25147-61. PubMed ID: 26501354 [TBL] [Abstract][Full Text] [Related]
18. Insight into the complex regulation of CD133 in glioma. Campos B; Herold-Mende CC Int J Cancer; 2011 Feb; 128(3):501-10. PubMed ID: 20853315 [TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity and genotoxicity of lipid nanocapsules. Le Roux G; Moche H; Nieto A; Benoit JP; Nesslany F; Lagarce F Toxicol In Vitro; 2017 Jun; 41():189-199. PubMed ID: 28323104 [TBL] [Abstract][Full Text] [Related]